"PT Phapros – Ungaran Pharmaceutical Plant – Central Java - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.
The "PT Phapros – Ungaran Pharmaceutical Plant – Central Java - Project Profile" is part of Timetric's database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders.
PT Phapros, a subsidiary of PT Rajawali Nusantara Indonesia (RNI), is planning to construct a pharmaceutical plant in Central Java, Indonesia.
The project involves the construction of a pharmaceutical plant with a production capacity of 6 billion tablets per annum.
It includes the construction of an administrative building, production facilities, storage facilities, a testing unit and other related facilities, and the installation of related machinery and equipment.
In July 2014, PT Phapros selected Ungaran as preferred location for the project. The other option was Kendal.
As of June 2015, PT Phapros is planning to issue US$14.9 million bonds to finance the construction of the project.
The project involves the construction of a pharmaceutical plant with a production capacity of 6 billion tablets per annum in Ungaran, Central Java, Indonesia.
The US$31 million project includes the following:
1. Construction of an administrative building
2. Construction of production facilities
3. Construction of storage facilities
4. Construction of testing and other related facilities